Skip to content
IMExaminer
IMExaminer
Toggle sidebar

Pulmonary Embolism With sPESI 0: What Still Has to Be True Before ED Discharge?

A zero sPESI score estimates low short-term clinical risk; it is not a discharge order. This case shows how teams pair the score with current physiology, treatment barriers, medication access, and follow-up before choosing home care.

IMExaminer Medical reviewer: Dr. Ali Ragab, MBBCH, MSc, MCAI 5 min read
Editorial illustration of hands reviewing a blank discharge checklist beside an unlabelled medication pack and carry-on, representing outpatient planning after pulmonary embolism.

A confirmed pulmonary embolism (PE) with an sPESI score of 0 can make emergency-department discharge seem automatic. It is not. The score estimates short-term mortality risk; it does not tell you whether this patient can safely manage treatment at home or whether another clinical or practical issue makes admission wiser.

Consider a 55-year-old man with a segmental PE after a 14-hour flight. His blood pressure is 135/85 mmHg, heart rate 108/min, respiratory rate 22/min, and oxygen saturation 94% on room air. If he has no history of cancer or chronic cardiopulmonary disease, his stated age and vital signs give him an sPESI of 0. Hypertension alone does not count as the chronic cardiopulmonary disease item, and heart rate is not part of sPESI. Neither fact makes the persistent tachycardia irrelevant to bedside judgment.

A low-risk score is not a discharge order

Risk assessment and disposition overlap, but they answer different questions. The flight offers context for how the clot may have occurred; it does not determine whether he needs monitoring now. A segmental clot, by itself, does not mandate admission either.

Assessment What it helps answer What it does not settle
sPESI or PESI Is the estimated short-term clinical risk low? Is home treatment medically and practically feasible for this person?
Hestia or a comparable disposition tool Is there a clinical or practical reason to prefer hospital care? Whether a concerning change in the patient’s condition can be ignored because a score is low
Troponin, BNP/NT-proBNP, and right-ventricular assessment Is there evidence that PE is affecting the heart, when further risk assessment is warranted? A stand-alone decision to discharge or give reperfusion treatment

A low score is reassuring, not a guarantee. A safe outpatient plan also depends on the patient’s evolving symptoms, bleeding risk, need for oxygen or other hospital-level care, ability to obtain anticoagulation promptly, and reliable follow-up. The patient’s goals and preferences belong in that decision too.

Recheck the patient behind the number

Repeat vital signs and assess their direction, not just the first set: Is his heart rate improving or rising? Is oxygenation stable on room air? Is he developing hypotension, syncope, confusion, worsening breathlessness, or signs of poor perfusion? A room-air saturation of 94% and a normal blood pressure are reassuring in context, but they do not replace reassessment.

Establish the baseline that could change interpretation: usual exercise tolerance and oxygen use; history of heart or lung disease, cancer, or prior VTE; recent bleeding; renal or liver disease; current medications; and ability to take oral treatment. Clarify pain control and whether another acute problem requires admission. If symptoms, oxygenation, or examination seem out of proportion to the initial assessment, consider a concurrent diagnosis such as acute coronary syndrome, pneumonia, pneumothorax, heart failure, or arrhythmia rather than attributing everything to the PE.

The case does not report right-ventricular findings or cardiac biomarkers. Their absence from the vignette is not proof that they are normal. Equally, a low sPESI alone does not mean every patient needs an echocardiogram or biomarker panel before discharge. If clinical severity is elevated or there are concerning findings, assess right-ventricular size and function and consider troponin and BNP/NT-proBNP. Abnormalities should prompt a fresh risk assessment and may support monitored care; they are not, by themselves, an order for thrombolysis.

Make the outpatient plan real before the patient leaves

Use a validated disposition tool, such as Hestia, to look for reasons home treatment may be unsuitable. Pay particular attention to hemodynamic instability, active bleeding or high bleeding risk, a need for ongoing oxygen or IV pain medication, need for an intervention, or another medical or social reason to stay. A checklist supports judgment; it does not replace it.

Then test whether the plan can actually work outside the hospital. Before discharge, the patient should have immediate access to the prescribed anticoagulant, understand how to take it and what to do if a dose is missed, and have a clear way to obtain rapid, reliable follow-up. Check that transportation, communication, and any needed support are in place. If medication access or follow-up is uncertain, solve that barrier first or choose observation or admission.

Evidence for outpatient treatment comes from strategies that combine a decision tool with clinician judgment and patient preference—not from sending every person with sPESI 0 home. That distinction is useful on rounds: the score opens the outpatient pathway; the whole-person assessment determines whether to use it.

For this patient, the stated findings support low clinical severity if the missing history confirms no other sPESI item. But the case does not establish his symptom trajectory, bleeding risk, pain control, home circumstances, medication access, or follow-up plan. Nor does it provide right-ventricular results; those should be considered if his clinical picture raises concern, not treated as an automatic testing requirement for every low-score patient. Discharge is reasonable if reassessment remains reassuring, no Hestia-type barrier or competing admission need is present, and a workable treatment and follow-up plan is secured. Otherwise, observation or admission is the safer decision.

Practical takeaways

  • sPESI 0 estimates low short-term mortality risk; it does not clear a patient for discharge.
  • A heart rate of 108 does not add an sPESI point, but its trend and clinical context still matter.
  • Use a disposition tool to identify treatment barriers, then confirm anticoagulant access and reliable follow-up.
  • Order biomarkers or RV imaging when clinical severity or findings warrant further assessment—not as a reflexive discharge hurdle.

Frequently asked questions

Keep learning

Case Discussion

Cirrhotic Variceal Bleeding: Should INR and Platelets Be Corrected?

With suspected variceal bleeding, an INR of 1.8 and platelets of 45,000/µL can trigger reflex transfusions. Learn why those results alone should not delay endoscopic hemostasis.

Study Tips

Corrected Calcium on Boards: Calculate It Without Calling It Ionized Calcium

For a calcium SAQ, calculate the requested albumin adjustment—but be precise about what the estimate can and cannot prove.

Medical Education

Pseudohyperkalemia: When the Sample, Not the Patient, Adds Potassium

A normal repeat does not identify the artifact. Trace how clotting, fragile blood cells, fist pumping, and specimen handling can raise measured potassium—and choose a confirmation that fits the suspected source.

We use cookies to enhance your experience. By clicking Accept, you agree to all analytics and advertising cookies. Terms of Use & Privacy Policy